View
1
Download
0
Category
Preview:
Citation preview
Expert Insights in Advanced ALK-Positive NSCLCAddressing Questions Faced by
Physicians in Clinical PracticeSATURDAY, 28 SEPTEMBER 2019 | 18:30 – 20:00
VENUE: FIRA GRAN VIA, BARCELONA, SPAIN | ROOM: ALICANTE AUDITORIUM, HALL 3
MODERATOR
Enriqueta Felip, MD, PhDHead of Lung and Thoracic Oncology Units University Hospital Vall D’Hebron Barcelona, Spain
PANELISTS
Marina Chiara Garassino, MDChief of Medical Thoracic Oncology Unit Medical Consultant Medical Oncology Division Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
Tony Mok, MD, FRCPCClinical Professor Department of Clinical Oncology The Chinese University of Hong Kong Hong Kong, China
Sanjay Popat, PhD, FRCPConsultant Medical Oncologist Royal Marsden Hospital Reader, Imperial College London London, United Kingdom
AGENDA
18:30IntroductionEnriqueta Felip, MD, PhD
18:35Expert Insights in 3 Patient Cases With Advanced ALK-Positive NSCLCEnriqueta Felip, MD, PhD
18:45The Patient Presenting With De Novo ALK-Positive Metastatic NSCLC: What Are the Best Options for Your Patient?Marina Chiara Garassino, MD and panel
19:05The Patient With ALK-Positive Metastatic NSCLC at Risk of CNS Progression: How Can We Determine and Reduce the Risk?Sanjay Popat, PhD, FRCP and panel
19:25The Patient Progressing After First Line Treatment With ALK-Targeted Therapy: What Are the Current Possibilities?Tony Mok, MD, FRCPC and panel
19:45Addressing Your QuestionsPanel
19:55Concluding RemarksEnriqueta Felip, MD, PhD
20:00Adjourn
ESMO 2019 INDUSTRY SATELLITE SYMPOSIUM
CPD
Refreshments offered by Medscape
Supported by an independent educational grant from Takeda.
This activity is certified for 1.5 CPD credits.
Recommended